The Business Times
business-time-50

Bayer Pharma continues to boost its presence in the Asia-Pacific

2015 regional revenue rises 7% to 4b euros; clinical trials triple in 9 years

google-preferred-sourceAdd BT as a preferred source
Nisha Ramchandani

Nisha Ramchandani

Published Fri, Mar 18, 2016 · 09:50 PM

    Singapore

    The number of clinical trials conducted by Bayer Pharmaceuticals in Asia Pacific has more than tripled since 2007 - from 21 to 68 - as the healthcare group strengthens its focus on the region.

    Here in Singapore, the number of trials has expanded nearly fourfold to 22 from six in the same time frame.

    TRENDING NOW

    Liang’s net worth more than doubled to US$36 billion, from around US$16.7 billion, according to the Bloomberg Billionaires Index. 

    DeepSeek founder Liang Wenfeng becomes the world’s richest AI model creator

    US Secretary of State Marco Rubio (far left) and Treasury Secretary Scott Bessent listening as President Donald Trump (centre) speaks to the media on the sidelines of a Nato summit in Ankara, July 8, 2026.

    A new kind of ‘ceasefire’ between US and Iran where talks, strikes are part of the same process

    Philippine’s Maharlika support for Petron through a credit facility shows the sovereign fund’s role in the nation’s energy security.

    Early payout from Philippines’ Maharlika Investment Fund raises eyebrows over its true nature

    A distinct separation of duties in a family enterprise protects both the business and the family. 

    Family businesses fail when members overstep their roles

    Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
    Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
    View More